ReviewPublished 12 October 2026Chimeric antigen receptor-engineered cell therapy for asthma: advances in targeting type 2 inflammation and translational challengesYifei Niu · Chenyang Jian · Peize Liu · Mengwei Wu · Haoyuan Li · Xu Li · Lili ZhiFrontiers in Immunologydoi 10.3389/fimmu.2026.1979396
ReviewPublished 7 October 2026The role of personalised medicine in treating high-risk neuroblastoma in paediatric patientsDaniele Ammeti · Debora Curci · Martina Franzin · Marco Rabusin · Melania Eva Zanchetta · Antonella FabrettoOncology Reviewsdoi 10.3389/or.2026.1850627
ReviewPublished 13 August 2026Functional genomics–guided design of CAR-T and CAR-NK therapies in hematological malignancies: aligning cellular engineering with immune escape and microenvironmental resistanceShiqi Cai · Yang Tan · Qian Yang · Juan HuangFrontiers in Genome Editingdoi 10.3389/fgeed.2026.1878460
